ADVERTISEMENT

Comments?
Help us improve Portfolio Grader.


Comments?
Help us improve Portfolio Grader.


Blue Chip Growth

Stock Report: Protalix Biotherapeutics, Inc. (PLX) Report Updated: Dec 09, 2017 | Print This Page

Get more stock ratings by Louis Navellier

Protalix Biotherapeutics, Inc. (PLX)

Rating: Buy Volatility: Aggressive
Total Grade: B Industry: Biotechnology
Competitors: NBIX,LGND,ABBV,MDGL

Stock Analysis

Rating: Monthly View

A
B
C
D
F
December January February March April May June July August September October November

Rating: Weekly View

This Week: B down no change
Last Week: B same no change
Two Weeks Ago: B up no change
service keys

Protalix Biotherapeutics, Inc.© quotemedia

Company Profile